Evidence map›Paper›PMID 40490996›Full record

ArticleBiotechnology journal2025

Replacement of Isoleucine and Leucine by their Keto Acids leads to increased formation of α-Hydroxy Acids in Chinese Hamster Ovary cells.

Philipp Reifenberg, Lara Rosenberger, Maxime Le Mignon, Aline Zimmer

Abstract read
In one paragraph

Article in Biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Philipp ReifenbergMerck Life Science KGaA, Upstream R&D, Darmstadt, Germany.ORCID https://orcid.org/0009-0001-5036-9573
Lara RosenbergerMerck KGaA, Darmstadt, Germany.
Maxime Le MignonMerck Life Science KGaA, Upstream R&D, Darmstadt, Germany.
Aline ZimmerMerck Life Science KGaA, Upstream R&D, Darmstadt, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keto isoleucine and keto leucine are bioavailable amino acid precursors in CHO cells producing biotherapeutics. Following their supplementation in a fed-batch culture with CHOK1 GS cells, quantitation of metabolites derived from the three branched-chain keto acids revealed a decrease of their decarboxylation products, but an accumulation of their α-hydroxy acids. The latter had minor effects on cell growth and productivity. L-lactate dehydrogenase was identified as the key enzyme forming valine's α-hydroxy acid.

Indexed as

Hydroxy AcidsIsoleucineKeto AcidsLeucineAnimalsBatch Cell Culture TechniquesCHO CellsCricetulusL-Lactate DehydrogenaseHydroxy AcidsIsoleucineKeto AcidsLeucineL-Lactate Dehydrogenasebranched‐chain amino acidsisoleucineleucinevalineα‐hydroxy acidsα‐keto acids

Identifiers

PMID40490996
PMCPMC12149483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.